Literature DB >> 14503906

1: Epidemiology and prevention of type 2 diabetes and the metabolic syndrome.

Jonathan E Shaw1, Donald J Chisholm.   

Abstract

The prevalence of type 2 diabetes in Australia has doubled over the past 20 years; more than 7% of Australian adults now have diabetes. An additional 16% of Australian adults have lesser abnormalities of glucose tolerance. Insulin resistance and increased cardiovascular risk occur in both these groups (the metabolic syndrome). 50% of cases of type 2 diabetes are undiagnosed; screening is indicated in everyone aged over 55 and in younger people with risk factors such as obesity, hypertension, family history or certain ethnic backgrounds. Dietary modification and increased physical activity have been shown to dramatically reduce the incidence of type 2 diabetes in those at high risk. General practitioners should target individuals at high risk, but this needs to be reinforced by community-wide preventive action. National prevention programs are needed, but GPs can contribute through screening and lifestyle advice.

Entities:  

Mesh:

Year:  2003        PMID: 14503906     DOI: 10.5694/j.1326-5377.2003.tb05677.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  21 in total

1.  A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.

Authors:  Qiang Wen; Fangqin Wu; Jinhua Yang; Jingjing Wu; Xiaomin Zhang; Meian He; Tangchun Wu; Longxian Cheng
Journal:  Biomed Rep       Date:  2015-04-20

2.  Identification of undiagnosed type 2 diabetes by systolic blood pressure and waist-to-hip ratio.

Authors:  M T T Ta; K T Nguyen; N D Nguyen; L V Campbell; T V Nguyen
Journal:  Diabetologia       Date:  2010-07-02       Impact factor: 10.122

Review 3.  Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.

Authors:  John Nicasio; Fadi El-Atat; Samy I McFarlane; Judith H LaRosa
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

4.  Estimating patient demographic profiles from practice location.

Authors:  Michael Shortt; William Hogg; Rose Anne Devlin; Grant Russell; Laura Muldoon
Journal:  Can Fam Physician       Date:  2012-04       Impact factor: 3.275

Review 5.  Controversies around gestational diabetes. Practical information for family doctors.

Authors:  Len Kelly; Laura Evans; David Messenger
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

Review 6.  Chromatin modifications associated with diabetes.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  J Cardiovasc Transl Res       Date:  2012-05-26       Impact factor: 4.132

7.  Cation-Independent Mannose 6-Phosphate Receptor Deficiency Enhances β-Cell Susceptibility to Palmitate.

Authors:  Aaron C Baldwin; Aaron Naatz; Richard N Bohnsack; Jacob T Bartosiak; Bryndon J Oleson; Polly A Hansen; Nancy M Dahms; John A Corbett
Journal:  Mol Cell Biol       Date:  2018-03-29       Impact factor: 4.272

8.  Polyphenolic-rich extracts of Andrographis paniculata mitigate hyperglycemia via attenuating β-cell dysfunction, pro-inflammatory cytokines and oxidative stress in alloxan-induced diabetic Wistar albino rat.

Authors:  Kikelomo Folake Jaiyesimi; Oludare Shadrach Agunbiade; Bashiru Olaitan Ajiboye; Olakunle Bamikole Afolabi
Journal:  J Diabetes Metab Disord       Date:  2020-11-15

9.  Mental disorders as risk factors: assessing the evidence for the Global Burden of Disease Study.

Authors:  Amanda J Baxter; Fiona J Charlson; Adele J Somerville; Harvey A Whiteford
Journal:  BMC Med       Date:  2011-12-16       Impact factor: 8.775

10.  Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia.

Authors:  Marian Abouzeid; Benjamin Philpot; Edward D Janus; Michael J Coates; James A Dunbar
Journal:  BMC Public Health       Date:  2013-03-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.